Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, November 27, 2009, 7:11AM ET - U.S. Markets open in 2 hours and 19 minutes. Dow Up 0.29% Nasdaq  0.00%
AdvanSource Biomaterials Corporation (ASB)On Nov 25: 0.26   0.00 (0.00%)  
MORE ON ASB
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
AdvanSource Biomaterials Corporation
229 Andover Street
Wilmington, MA 01887
United States - Map
Phone: 978-657-0075
Fax: 978-657-0074
Web Site: http://www.AdvBiomaterials.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:20

BUSINESS SUMMARY 
AdvanSource Biomaterials Corporation offers polymer materials for use in the design and development of medical devices in the United States. The company’s biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states. It also develops CardioPass Synthetic Coronary Artery Bypass Graft, which is an alternative to patients with insufficient or inadequate native vessels for use in bypass surgery as a result of repeat procedures, trauma, disease, or other factors. The company manufactures and sells custom polymers under the trade names of ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, HydroThane, and PolyBlend. It sells its products directly to customers. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on AdvanSource Biomaterials Corporation


    CORPORATE GOVERNANCE 
    AdvanSource Biomaterials Corporation's Corporate Governance Quotient (CGQ®) as of 6-Nov-09 is better than 24.9% of CGQ Universe companies and 12.5% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Michael F. Adams , 52
    Chief Exec. Officer, Pres, Sec., Treasurer
    $ 328.00K $ 0
    Mr. Michael Szycher Ph.D., MBA, 68
    Founder and Sr. Scientific Advisor
    N/A N/A
    Mr. David Volpe , 53
    Acting Chief Financial Officer and Principal Accounting Officer
    N/A N/A
    Mr. Ajay Nagle ,
    Head of Legal
    N/A N/A
    Ms. Khristine Carroll ,
    Global Sales Director
    N/A N/A
    Dollar amounts are as of 31-Dec-09 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis